Systemic endothelial dysfunction in COPD patients – study on 60 cases Source: Eur Respir J 2004; 24: Suppl. 48, 61s Year: 2004
Systemic inflammation and endothelial dysfunction in patient with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 143s Year: 2007
Vascular dysfunction and systemic inflammation in patients with COPD Source: Annual Congress 2011 - COPD: human studies Year: 2011
Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 768s Year: 2007
Evaluation of endothelial dysfunction at the patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 316s Year: 2004
Correction of endothelial dysfunction in patients with COPD, IPF Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010
The role of smoking in development of endothelial dysfunction in patients with COPD in combination with AH Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment Year: 2011
Pulmonary hypertension and endothelial dysfunction in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007
Differences in vessel endothelium function in severe COPD and severe asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 404s Year: 2006
Role of endothelial dysfunction, disturbance of haemostatic reactions in pathogenesis of acute exacerbation of chronic obstructive pulmonary disease (AE COPD) Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011
Systemic inflammation and vascular dysfunction in patients with OSA Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I Year: 2011
Do COPD patients have a pulmonary vascular phenotype? Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously! Year: 2019
Endothelial dysfunction at the patients with COPD with pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001
The link between systemic inflammation and pulmonary hypertension in patients with stable COPD Source: Eur Respir J 2005; 26: Suppl. 49, 53s Year: 2005
Increased arterial remodelling in smokers and mild-moderate COPD patients are indicative of potential early onset of pulmonary hypertension. Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021
Increased rho-kinase activity is related to pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008
Determinants of endothelial function in patients with COPD Source: Eur Respir J 2013; 42: 1194-1204 Year: 2013
Gender differences in formation of endothelial dysfunction (ED) extension in COPD patients Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Evidence of renal and pulmonary endothelial dysfunction in chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – New signalling pathways in COPD Year: 2016
Do hospitalized COVID-19 patients have endothelial vascular dysfunction? A cohort study Source: Virtual Congress 2021 – Highlights in COVID-19 diagnosis and treatment Year: 2021